Desensitization With Bortezomib Before a Living Kidney Donation

Trial Profile

Desensitization With Bortezomib Before a Living Kidney Donation

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 05 Oct 2016

At a glance

  • Drugs Bortezomib (Primary)
  • Indications Renal transplant rejection
  • Focus Pharmacodynamics
  • Acronyms VELDON
  • Most Recent Events

    • 28 Sep 2016 Planned End Date changed from 1 Jul 2016 to 1 Mar 2018.
    • 28 Sep 2016 Planned primary completion date changed from 1 Jul 2016 to 1 Mar 2017.
    • 08 May 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top